In the majority of studies, elevated Treg fractions were documented among peripheral blood CD4+ T cells of patients with glioblastoma (60, 68–70), even in cases with severe CD4+ T cell lymphopenia (<200 cells/μL) and regardless of steroid use (70). This evidence concerns the gene CD4 and glioblastoma.